LB Pharmaceuticals Inc Common Stock (LBRX) vs Seaport Therapeutics, Inc. Common Stock (SPTX)

A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and Seaport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
LB Pharmaceuticals Inc Common Stock logo
LBRX
LB Pharmaceuticals Inc Common Stock
$982M
$34.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Seaport Therapeutics, Inc. Common Stock logo
SPTX
Seaport Therapeutics, Inc. Common Stock
$930M
$17.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LBRX vs SPTX

growth of $100 · dividends reinvested · last 1y
LBRX +10.1% (+10.1%/yr)SPTX -6.8% (-6.8%/yr)LBRX compounded faster over this window
80100120140160Start $100$110$93
LBRX SPTX

LBRX vs SPTX: by the numbers

  • •LBRX is the larger company ($982M vs $930M market cap).

Metrics side by side

Valuation

MetricLBRXSPTX
P/B ratio2.962.20

Profitability

MetricLBRXSPTX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-25.78%N/A
ROIC-28.14%-36.95%

Go deeper

Full LBRX analysisFull SPTX analysisInteractive comparison tool

Dig into the metrics

LB Pharmaceuticals Inc Common Stock ROESeaport Therapeutics, Inc. Common Stock ROELB Pharmaceuticals Inc Common Stock operating marginSeaport Therapeutics, Inc. Common Stock operating marginLB Pharmaceuticals Inc Common Stock revenue growthSeaport Therapeutics, Inc. Common Stock revenue growthLB Pharmaceuticals Inc Common Stock free cash flowSeaport Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.